Variation in therapeutic strategies for the management of severe COVID-19 in India- A nationwide cross-sectional survey
Jagiasi et al.,
Variation in therapeutic strategies for the management of severe COVID-19 in India- A nationwide..,
The International Journal of Clinical Practice, doi:10.1111/ijcp.14574 (Review)
Survey of medication use for severe COVID-19 in India, showing 33% adoption of ivermectin as of January 2021.
Jagiasi et al., 25 Jun 2021, peer-reviewed, 19 authors.
Abstract: Received: 1 March 2021
|
Revised: 22 June 2021
|
Accepted: 24 June 2021
DOI: 10.1111/ijcp.14574
ORIG INAL PAPER
Respiratory Medicine
Variation in therapeutic strategies for the management of
severe COVID-19 in India: A nationwide cross-sectional survey
Bharat Jagiasi1 | Prashant Nasa2
| Gunjan Chanchalani3 | Ahsan Ahmed4 |
Ajith Kumar AK5 | Kanwalpreet Sodhi6 | Kishore Mangal7 | Manoj K. Singh8 |
Nitesh Gupta9 | Prasanna U. Bidkar10
| Ranvir S. Tyagi11 | Reshu G. Khanikar12 |
Swagata Tripathy13 | Swapna Khanzode14 | Kesavarapu Subba Reddy15 |
Saurabh Saigal16 | Vijay Anand Sivakumar17 | Yash Javeri18 | Seema S. Tekwani19
1
Critical Care Department, Reliance Hospital, Navi Mumbai, Maharashtra, India
2
Critical Care Medicine, NMC Specialty Hospital, Dubai, United Arab Emirates
3
Critical Care Medicine, Cumballa Hill Hospital, Mumbai, Maharashtra, India
4
Anesthesiology and Critical Care, KPC Medical College and Hospital, Kolkata, West Bengal, India
5
Critical Care Medicine, Manipal Hospitals, Bengaluru, Karnataka, India
6
Department of Critical Care, Deep Hospital, Ludhiana, Punjab, India
7
Critical Care, Eternal Hospital, Jaipur, Rajasthan, India
8
Critical Care & Sleep Medicine, Apollo Hospital, Ahmedabad, Gujarat, India
9
Department of Pulmonary, Critical Care and Sleep Medicine, VMMC and Safdarjung Hospital, New Delhi, India
10
Department of Anaesthesiology and Critical Care, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
11
Department of Anaesthesia and Critical Care Medicine, Synergy Plus Hospital, Agra, Uttar Pradesh, India
12
Department of Critical Care Medicine, Health City Hospital, Guwahati, Assam, India
13
Anesthesia & Intensive Care, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
14
Medicine and Critical Care, Wockhardt Multispecialty Hospital, Nagpur, Maharashtra, India
15
Department Of Critical Care Medicine, Apollo Health City, Hyderabad, Telangana, India
16
Anaesthesia and Intensive Care, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
17
Velammal Medical college and Research Centre, Madurai, Tamil Nadu, India
18
Critical Care Medicine and Emergency Medicine, Regency Super Specialty Hospital, Lucknow, Uttar Pradesh, India
19
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University School of Medicine, Atlanta, GA, USA
Correspondence
Prashant Nasa, Critical Care Medicine,
NMC Specialty Hospital, PO box 7832, Al
Nahda-2, Dubai, United Arab Emirates.
Email: dr.prashantnasa@hotmail.com
Abstract
Aim: During the pandemic of coronavirus disease 2019 (COVID-19), the physicians
are using various off-label therapeutics to manage COVID-19. We undertook a cross-
sectional survey to study the current variation in therapeutic strategies for managing
severe COVID-19 in India.
Methods: From January 4 to January 18, 2021, an online cross-sectional survey was
conducted among physicians involved in the management of severe COVID-19. The
survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adjuvant
therapies.
Results: 1055 respondents (from 24 states and five union territories), of which 64.2%
were consultants, 54.3% working in private hospitals, and 39.1% were from critical
care medicine completed the survey. Remdesivir (95.2%), antithrombotics (94.2%),
Int J Clin Pract...
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit